One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Insights and Advances Into Treatments for Major Depression
Ned H. Kalin, M.D.
doi : 10.1176/appi.ajp.20230041
Volume 180, Issue 3
Applying Functional Imaging to Clinical Practice: Are We Making Progress Toward Its Promise?
Stephen M. Strakowski, M.D.
Hitting the Target of Image-Guided Psychiatry?
Shan H. Siddiqi, M.D., and Noah S. Philip, M.D.
A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications
Michael E. Thase, M.D.
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape
Manish K. Jha, M.B.B.S., Sanjay J. Mathew, M.D.
Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder
Sofie Hasseris, B.Sc., Clara Albiñana, M.Sc., Bjarni J. Vilhjalmsson, M.Sc., Ph.D., Preben B. Mortensen, M.D., D.M.Sc., Søren D. Østergaard, M.D., Ph.D., Katherine L. Musliner, M.P.H., Ph.D.
Moderate Alcohol Consumption and Depression: A Marginal Structural Model Approach Promoting Causal Inference
Rachel Visontay, B.A.(Hons), Louise Mewton, Ph.D., Tim Slade, Ph.D., Izzuddin M. Aris, Ph.D., Matthew Sunderland, Ph.D.
Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy
Boadie W. Dunlop, M.D., Jungho Cha, Ph.D., Ki Sueng Choi, Ph.D., Justin K. Rajendra, B.A., Charles B. Nemeroff, M.D., Ph.D., W. Edward Craighead, Ph.D., Helen S. Mayberg, M.D.
Functional Connectivity Mapping for rTMS Target Selection in Depression
Immanuel G. Elbau, M.D., Ph.D., Charles J. Lynch, Ph.D., Jonathan Downar, M.D., Ph.D., Fidel Vila-Rodriguez, M.D., Ph.D., Jonathan D. Power, M.D., Ph.D., Nili Solomonov, Ph.D., Zafiris J. Daskalakis, M.D., Ph.D., Daniel M. Blumberger, M.D., Conor Liston, M.D., Ph.D. See fewer authors
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Gary S. Sachs, M.D., Paul P. Yeung, M.D., M.P.H., Ludmyla Rekeda, Ph.D., Arifulla Khan, M.D., Julie L. Adams, M.D., M.P.H., Maurizio Fava, M.D.
